The Cooper Companies Inc. ($COO) Stock Forecast: Down 2.4% Today

What is The Cooper Companies Inc.?

COO is a stock that experienced a strong bearish movement today.

Why is The Cooper Companies Inc. going down?

COO stock is down 2.4% on Apr 15, 2026 14:35

• The resignation of Antalpha Platform Holding's CEO and COO could have created uncertainty and negative sentiment among investors, leading to a sell-off of COO shares.
• The news about CooperVision's upcoming symposium in Tokyo may have diverted investor attention towards other companies in the eye care industry, causing a decrease in demand for COO stock.
• The FDA's expansion of age indication for STAAR Surgical's EVO ICL could have shifted investor focus towards competitors in the refractive market, impacting COO's performance.
• Cambiar Investors LLC's increased stake in The Cooper Companies, Inc. might have signaled to investors a potential shift in the market dynamics within the medical device industry, influencing the bearish movement of COO.

COO Price Chart

COO Technical Analysis

COO News

Antalpha Platform Holding CEO and COO step down

Antalpha Platform Holding's CEO, Kelvin Du, and COO, Aaron Du, have stepped down from their positions. This leadership change marks a significant development for the platform.

https://www.msn.com/en-us/money/companies/antalpha-platform-holding-ceo-and-coo-step-down/ar-AA20T63E

CooperVision to Bring its 6th Asia-Pacific Myopia Management Symposium (APMMS) to Tokyo

CooperVision announced its 6th Asia-Pacific Myopia Management Symposium (APMMS) will take place in Tokyo on May 10, 2026, themed "Eyes Have Dreams." The hybrid event aims to advance pediatric myopia management through knowledge-sharing, clinical skill strengthening, and consensus-building on control strategies among global eye care professionals. Regional Connect Country Editions will also be held in Seoul and Taipei to provide localized insights.

https://finance.yahoo.com/sectors/healthcare/articles/coopervision-bring-6th-asia-pacific-010000077.html

FDA Expands Age Indication for STAAR Surgical’s EVO ICL

The FDA has expanded the age indication for STAAR Surgical's EVO/EVO+ Visian Implantable Collamer Lenses (ICL) to include patients aged 21 to 60, up from 21 to 45. This expansion, supported by three-year FDA clinical trial safety data, significantly increases the addressable U.S. market for the EVO ICL and comes as the U.S. refractive market shifts away from laser-based procedures. The EVO ICL is increasingly becoming the preferred solution for patients with high myopia.

https://www.mpo-mag.com/breaking-news/fda-expands-age-indication-for-staar-surgicals-evo-icl/

Can WD-40’s (WDFC) Sales Growth and Margin Gains Offset Pressure on Profits?

WD-40 Company increased sales to US$161.67 million in Q2 2026, up from US$146.10 million a year earlier, but net income and diluted EPS saw a decline. Despite this, management reaffirmed full-year 2026 guidance, citing strong maintenance product growth and expanded gross margins. The article discusses how these factors might influence WD-40's investment narrative, with the company forecasting US$630-US$655 million in net sales and US$5.75-US$6.15 diluted EPS for the year.

https://simplywall.st/stocks/us/household/nasdaq-wdfc/wd-40/news/can-wd-40s-wdfc-sales-growth-and-margin-gains-offset-pressur

Cambiar Investors LLC Boosts Stake in The Cooper Companies, Inc.

Cambiar Investors LLC has significantly increased its stake in The Cooper Companies, Inc. by acquiring over 55,000 shares, valued at approximately $4.555 million, during the fourth quarter of 2025. This move signals Cambiar Investors' confidence in the medical device company's innovation and growth potential, especially in its contact lens and women's health product lines. The investment is expected to support Cooper Companies' expansion and profitability in the medical device industry.

https://nationaltoday.com/us/ca/san-ramon/news/2026/04/12/cambiar-investors-llc-boosts-stake-in-the-cooper-companies-inc/

Trending Today

Cadence Design Systems Inc. ($CDNS) Stock Forecast: Up 5.0% Today

Advanced Micro Devices Inc. ($AMD) Stock Forecast: Up 6.0% Today

Texas Instruments Incorporated ($TXN) Stock Forecast: Up 5.1% Today

Estee Lauder Companies Inc. (The) ($EL) Stock Forecast: Up 10.6% Today

ON Semiconductor Corporation ($ON) Stock Forecast: Up 8.1% Today

Hewlett Packard Enterprise Company ($HPE) Stock Forecast: Up 11.3% Today

Ross Stores Inc. ($ROST) Stock Forecast: Up 6.9% Today

Corsair Gaming Inc. ($CRSR) Stock Forecast: Up 9.8% Today

Skyworks Solutions Inc. ($SWKS) Stock Forecast: Up 9.3% Today

Cencora Inc. ($COR) Stock Forecast: Up 5.1% Today

The Cooper Companies Inc. Price History

06.02.2026 - COO Stock was down 4.3%

• The stock saw a decline of over 2% and continued to decrease during pre-market trading, despite the company's upward revision of full-year guidance and growth in its key segments.
• An investment firm raised COO's price target to $101.00, reflecting a positive outlook, but the market responded with a bearish tone.
• Insider stock purchases by Cramer Rosenthal Mcglynn LLC and other institutions indicate confidence in the company, although market sentiment remains uncertain.
• The market's bearish trend may be linked to investors taking profits following the stock's recent strong performance, despite the company's favorable earnings and guidance updates.

06.02.2026 - COO Stock was down 5.1%

• Forecasts on COO were adjusted by analysts post the Q1 earnings, resulting in varied reactions that affected the stock negatively.
• COO exceeded earnings expectations, raised its FY26 forecast, but faced difficulties in certain markets and segments, causing a decrease in the stock price.
• Barclays predicted a significant price increase for COO, suggesting a potential upside of 33.7%. Despite this, concerns regarding core vision growth and valuation may have contributed to the stock's decline.
• Even with a positive financial performance showing revenue growth and an increase in EPS, market challenges in specific regions weighed down on COO's stock price, leading to the recent bearish movement.

05.11.2025 - COO Stock was up 6.3%

• After exceeding fourth-quarter earnings expectations and providing positive financial guidance for fiscal 2026, COO stock saw a significant uptrend.
• Investor confidence in COO was further strengthened by the company's decision to conduct a thorough review of its portfolio to streamline operations and potentially engage in transactions to create value.
• Analysts have raised their price targets for COO stock, attributing the bullish market movement to the company's strong performance and strategic initiatives.
• The market's positive response to COO's robust earnings, revenue growth, and optimistic guidance underscores confidence in the company's future growth prospects and efforts to enhance shareholder value through strategic actions.

05.11.2025 - COO Stock was up 7.3%

• COO surpassed Q4 fiscal 2025 earnings and sales estimates due to robust MyDay contact lens adoption and operational enhancements, leading to substantial revenue growth in both segments.
• Mizuho and Baird analysts raised their price targets for COO, indicating optimism about the company's performance and potential for long-term shareholder value.
• COO's formal strategic review announcement aimed at boosting shareholder value through initiatives such as market share expansion and operational efficiency has reinforced investor confidence and contributed to the bullish market movement.

05.11.2025 - COO Stock was up 12.4%

• Strong Q4 2025 earnings results revealed an EPS of $1.15, surpassing expectations, indicating steady market share growth for CooperVision and robust revenue increase for CooperSurgical.
• Various analysts have raised price targets for the company, with one setting it at $100 and another at $98, while also commencing a formal evaluation to enhance shareholder value, contributing to the optimistic market sentiment.
• Positive developments such as the CEO's resignation, the initiation of a strategic review, and a substantial $2.0 billion share repurchase plan have all instilled confidence among investors in Cooper Companies.
• Despite a reduction in investment by Fisher Asset Management LLC, the overall favorable outlook, impressive financial performance, and strategic actions have driven the company's stock price upwards.

15.03.2026 - COO Stock was down 2.4%

• The resignation of Antalpha Platform Holding's CEO and COO could have created uncertainty and negative sentiment among investors, leading to a sell-off of COO shares.
• The news about CooperVision's upcoming symposium in Tokyo may have diverted investor attention towards other companies in the eye care industry, causing a decrease in demand for COO stock.
• The FDA's expansion of age indication for STAAR Surgical's EVO ICL could have shifted investor focus towards competitors in the refractive market, impacting COO's performance.
• Cambiar Investors LLC's increased stake in The Cooper Companies, Inc. might have signaled to investors a potential shift in the market dynamics within the medical device industry, influencing the bearish movement of COO.